CVS Health (CVS) Declares $0.50 Quarterly Dividend; 3.3% Yield

Closely watched opioid trial in New York postponed due to coronavirus

(Reuters) - A highly anticipated trial pitting New York state against McKesson Corp (NYSE: MCK), Johnson & Johnson (NYSE: JNJ), CVS Health Corp (NYSE: CVS) and others for allegedly fueling the opioid epidemic has been postponed due to the coronavirus outbreak, according to the court.

The postponement of the March 20 jury trial was a precautionary measure due to the number of people traveling to attend, according to a spokesman for New York Attorney General Letitia James.

CVS Health (CVS) to Acquire, Rebrand and Operate Schnucks Pharmacies

CVS Pharmacy, Inc., a subsidiary of CVS Health Corporation (NYSE: CVS), and Schnucks announced today that they have entered into a definitive agreement for CVS Pharmacy and certain of its subsidiaries to acquire Schnuck Markets Inc.'s retail and specialty pharmacy businesses.

Through this agreement, CVS Pharmacy and its subsidiaries will acquire and operate 99 of the grocer's pharmacies and will brand them as CVS Pharmacy. Additionally, CVS Pharmacy and its subsidiaries will acquire the prescription files from 11 Schnucks pharmacies and transfer them to nearby CVS Pharmacy locations.

This strategic relationship... More

CVS Health (CVS) Announces Additional COVID-19 Resources Focused on Patient Access

CVS Health (NYSE: CVS) is taking additional steps across the company to address the COVID-19 outbreak and protect patient access to medication.

"Being committed to the welfare of those we serve means being responsive to evolving needs and acting swiftly. This is particularly true in times of uncertainty," said Troyen Brennan, M.D., M.P.H., Executive Vice President and Chief Medical Officer, CVS Health. "The latest steps we're taking will help ensure patients of all ages have every option available to them... More